Bluejay Diagnostics, Inc. (BJDX) vs Telesis Bio Inc. (TBIO)

Bluejay Diagnostics, Inc. and Telesis Bio Inc. are both Medical Devices companies. Telesis Bio Inc. is the larger, with a market value of $5.3M against $4.3M — 1.2× the size. Telesis Bio Inc. has negative trailing earnings, so its P/E is not meaningful; Bluejay Diagnostics, Inc. trades at 1.2×. Bluejay Diagnostics, Inc. has the higher net margin (0.00% vs −287.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Bluejay Diagnostics, Inc. leads on 6 and Telesis Bio Inc. on 6.

Valuation

Metric BJDX TBIO Medical Devices median
P/E 1.15 n/m 22.18
P/S n/m n/m 2.70
P/B 0.20 n/m 2.46
Price to free cash flow n/m n/m 22.53
EV/EBITDA 1.01 n/m 11.78
EV/Sales n/m 0.10 2.38
Earnings yield 86.67% 0.00% (8.22%)
Free cash flow yield (326.05%) 0.00% (7.80%)

Profitability

Metric BJDX TBIO Medical Devices median
Gross margin 0.00% 45.62% 56.01%
Operating margin 0.00% (265.73%) (15.03%)
Net margin 0.00% (287.90%) (20.40%)
Free cash flow margin 0.00% (143.25%) (7.24%)
Return on equity (98.89%) 1,013.88% (15.32%)
Return on assets (81.07%) (73.87%) (19.72%)
Return on invested capital 0.00% 0.00% (10.33%)

Growth

Metric BJDX TBIO Medical Devices median
Revenue growth (TTM) — (38.09%) 8.80%
EPS growth (last fiscal year) 96.66% 0.61% —
Revenue growth, 5-year CAGR — 41.76% 15.23%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BJDX TBIO Medical Devices median
Debt to equity 0.00 (0.23) 0.07
Current ratio 4.64 1.23 2.50
Net debt to EBITDA 0.76 0.46 0.49

Dividend

Metric BJDX TBIO Medical Devices median
Dividend yield — — 0.94%
Payout ratio 0.00 0.00 0.00

Size

Metric BJDX TBIO Medical Devices median
Market cap 4.28m 5.31m 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack